Liraglutide offers a novel approach for managing hind-limb ischemia, a severe vascular complication of diabetes. In experimental models, liraglutide significantly improved blood flow reperfusion and enhanced capillary density in ischemic tissues. These effects were driven by its ability to activate endothelial nitric oxide synthase (eNOS) and ERK1/2 signaling pathways, improving endothelial cell migration and proliferation. In vitro studies with human umbilical vein endothelial cells demonstrated liraglutide's capacity to overcome hyperglycemia-related vascular dysfunction. Its GLP-1 receptor-mediated actions underline its potential for stimulating angiogenesis, providing a promising treatment for peripheral artery disease and ischemia.
Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Victorizafei Pen by Keifei Pharma, consult with your doctor or healthcare professional.
Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.
Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.
Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N.H., Wang, L., Chen, N., Luo, M., Wu, J., & Li, R. (2023) 'Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model', Journal of the American Heart Association.